Header Logo

Connection

AYSE MINDIKOGLU to Aged

Back to Details
This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Aged.
AYSE MINDIKOGLU
Connection Strength
0.361
Aged
  1. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.042
  2. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.042
  3. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and?Dimethylarginines. Clin Gastroenterol Hepatol. 2016 Apr; 14(4):624-632.e2.
    View in: PubMed
    Score: 0.035
  4. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014; 39(6):543-52.
    View in: PubMed
    Score: 0.033
  5. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology. 2014 Apr; 59(4):1532-42.
    View in: PubMed
    Score: 0.031
  6. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012 Apr; 25(4):409-15.
    View in: PubMed
    Score: 0.028
  7. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009 Jul; 15(7):719-29.
    View in: PubMed
    Score: 0.023
  8. Hepatitis C in the elderly: epidemiology, natural history, and treatment. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):128-34; quiz 124.
    View in: PubMed
    Score: 0.022
  9. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008 Feb 15; 85(3):359-68.
    View in: PubMed
    Score: 0.021
  10. Imatinib mesylate (gleevec) hepatotoxicity. Dig Dis Sci. 2007 Feb; 52(2):598-601.
    View in: PubMed
    Score: 0.019
  11. Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa. Dig Dis Sci. 2003 Jun; 48(6):1130-5.
    View in: PubMed
    Score: 0.015
  12. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.011
  13. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.011
  14. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.010
  15. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009 Dec; 15(12):1814-20.
    View in: PubMed
    Score: 0.006
  16. Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. J Gastroenterol Hepatol. 2005 Jun; 20(6):882-9.
    View in: PubMed
    Score: 0.004
  17. Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic hepatitis C. J Viral Hepat. 2003 Jul; 10(4):310-7.
    View in: PubMed
    Score: 0.004
  18. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci. 2003 Jul; 48(7):1414-24.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.